We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look ...

Vertiv (NYSE:VRT) focuses on creating and maintaining essential digital infrastructure solutions and lifecycle services for ...

We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look ...

Learn more about whether Lantheus Holdings, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.